Evidence map›Paper›PMID 19641066›Full record

ArticleJournal of clinical microbiology2009

Rapid semiautomated subtyping of influenza virus species during the 2009 swine origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin.

Michael E Bose, Eric T Beck, Nate Ledeboer, Sue C Kehl, Lisa A Jurgens, Teresa Patitucci, Lorraine Witt, Elizabeth LaGue, Patrick Darga, Jie He and 3 more

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Michael E BoseDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Eric T Beck
Nate Ledeboer
Sue C Kehl
Lisa A Jurgens
Teresa Patitucci
Lorraine Witt
Elizabeth LaGue
Patrick Darga
Jie He
Jiang Fan
Swati Kumar
Kelly J Henrickson
Pediatrics and Genetics · USChildren's Hospital of Wisconsin · USMedical College of Wisconsin · US

Funding

Rapid point-of-care diagnostic for bioterrorism "A" agents and Pandemic influenzaU01AI070428 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI HENRICKSON, KELLY J. · 2006 to 2010
$8.5M
Diagnostics for Sepsis and Community-Acquired PneumoniaU01AI066584 · NIAID · NEXOGEN, INC. · PI MATHER, PH.D., ELIZABETH L · 2005 to 2009
$2.4M
Multipled POC device for antigen/molecular detection of influenza & other virusesU01AI077988 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI HENRICKSON, KELLY J. · 2008 to 2011
$1.9M
NIAID NIH HHS U01 AI066584NIAID NIH HHS U01-AI066584NIAID NIH HHS U01 AI070428NIAID NIH HHS U01-AI070428NIAID NIH HHS U01 AI077988NIAID NIH HHS UO1-AI77988PHS HHS 200-2008-25466
6 · The paper itself

Abstract

In the spring of 2009, a novel influenza A (H1N1) virus (swine origin influenza virus [S-OIV]) emerged and began causing a large outbreak of illness in Milwaukee, WI. Our group at the Midwest Respiratory Virus Program laboratory developed a semiautomated real-time multiplex reverse transcription-PCR assay (Seasonal), employing the NucliSENS easyMAG system (bioMérieux, Durham, NC) and a Raider thermocycler (HandyLab Inc., Ann Arbor, MI), that typed influenza A virus, influenza B virus, and respiratory syncytial virus (RSV) and subtyped influenza A virus into the currently circulating H1 and H3 subtypes, as well as a similar assay that identified H1 of S-OIV. The Seasonal and H1 S-OIV assays demonstrated analytical limits of detection of <50 50% tissue culture infective doses/ml and 3 to 30 input copies, respectively. Testing of the analytical specificities revealed no cross-reactivity with 41 and 26 different common organisms and demonstrated outstanding reproducibility of results. Clinical testing showed 95% sensitivity for influenza A virus and influenza B virus and 95 and 97% specificity compared to tissue culture. Comparisons of results from other molecular tests showed levels of positive agreement with the Seasonal and H1 S-OIV assay results of 99 and 100% and levels of negative agreement of 98 and 100%. This study has demonstrated the use of a semiautomated system for sensitive, specific, and rapid detection of influenza A virus, influenza B virus, and RSV and subtyping of influenza A virus into human H1 and H3 and S-OIV strains. This assay/system performed well in clinical testing of regular seasonal influenza virus subtypes and was outstanding during the 2009 Milwaukee S-OIV infection outbreak. This recent outbreak of infection with a novel influenza A (H1N1) virus also demonstrates the importance of quickly distributing information on new agents and of having rapid influenza virus subtyping assays widely available for clinical and public health decisions.

Indexed as

Disease OutbreaksAutomationDNA PrimersGenotypeHumansInfluenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza B virusInfluenza, HumanReproducibility of ResultsRespiratory Syncytial VirusesSensitivity and SpecificityVirologyWisconsinDNA Primers

Identifiers

PMID19641066
PMCPMC2738075
OpenAlexW2162191803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.